Steven B. Ruchefsky, Director at Kite Pharma, Inc. (KITE), bought 1,400 shares at $69.50 ($97K) on 2017-05-09, disclosed to the SEC on 2017-05-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |